Stanley Lipkowitz
0000-0002-6103-2255
National Cancer Institute
2 papers found
Refreshing results…
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
Missing publications? Search for publications with a matching author name.